SGMT
HealthcareSagimet Biosciences Inc.
$5.54
$-0.45 (-7.51%)
Jan 5, 2026
Price History (1Y)
Analysis
Sagimet Biosciences Inc. is a biotechnology company operating in the healthcare sector with a market capitalization of $180.17 million and 14 employees. It operates within the industry of biotechnology. The company's financial health indicates significant losses, as evidenced by a net income of -$57,671,000 over the trailing twelve months. Additionally, Sagimet Biosciences Inc. reports free cash flow of -$26,935,376 during the same period. The balance sheet shows $116.69 million in cash and $115,000 in debt. Profitability metrics, including gross margin, operating margin, and profit margin, are all reported as 0.0%. The company's valuation context is characterized by a negative forward P/E ratio of -2.90, indicating potential undervaluation or significant losses. The price to book ratio stands at 1.51. Sagimet Biosciences Inc.'s beta, which measures volatility relative to the market, is 3.44.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs, such as various solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Visit website →Key Statistics
- Market Cap
- $180.17M
- P/E Ratio
- N/A
- 52-Week High
- $11.41
- 52-Week Low
- $1.73
- Avg Volume
- 579.24K
- Beta
- 3.44
Company Info
- Industry
- Biotechnology
- Exchange
- NGM
- Country
- United States
- Employees
- 14